Patent · US Active

Process for the separation of enantiomers of piperazine derivatives

US10344021B2 · kind B2 · utility

15Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 24, 2017
Grant dateJul 9, 2019
Priority date
Expiry dateFeb 24, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/07
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to a process for preparing either enantiomer of a compound of formula (I), wherein X, Y and n have the meaning given in claim 1, with high enantiomeric excess (e.e.), by chiral resolution in the presence of a non-racemic, chiral acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.